August 27, 2016 10:59 AM ET

Biotechnology

Company Overview of PNP Therapeutics, Inc.

Company Overview

PNP Therapeutics, Inc., a biopharmaceutical company, develops a platform technology and proprietary products for the treatment of cancer based on the selective expression of E. coli purine nucleoside phosphorylase. The company was incorporated in 2000 and is based in Birmingham, Alabama.

15 Richard Arrington Jr. Boulevard North

Birmingham, AL 35203-4121

United States

Founded in 2000

Phone:

205-381-6668

Key Executives for PNP Therapeutics, Inc.

President and Director
Co-Founder, Director and Member of Scientific Advisory Board
Co-Founder, Vice President, Secretary, Director and Member of Scientific Advisory Board
Compensation as of Fiscal Year 2016.

PNP Therapeutics, Inc. Key Developments

PNP Therapeutics Inc. Receives Orphan Drug Status for Gedeptin

PNP Therapeutics Inc. announced the Food and Drug Administration has granted orphan drug status to Gedeptin™, the company's lead product candidate (adenoviral vector expressing E. coli purine nucleoside phosphorylase gene) for the intratumoral treatment of anatomically accessible oral and pharyngeal cancers, including cancers of the lip, tongue, gum, floor of mouth, salivary gland and other oral cavities. The orphan drug designation is awarded to drugs designed to treat a rare disease or condition that affects fewer than 200,000 people in the U.S., and it is applied specifically to novel therapeutics that represent a major improvement. Orphan drug status provides regulatory incentives, reduced fees, and a more rapid review by the FDA, and stipulates that competing therapies can be blocked from the market for up to seven years. Additionally, this status qualifies the drug sponsor for various development incentives, including tax credits for qualified clinical testing.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 25, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PNP Therapeutics, Inc., please visit www.pnptherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.